arrow
J

John E. Mullinax

h lee moffitt cancer center & research institute
H指数:30
被引数:3,415

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma

免疫因素和肿瘤微环境是影响晚期黑色素瘤对肿瘤浸润淋巴细胞疗法反应的决定因素

Med
IF11.8
2026-07-290
PRE
Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic retroperitoneal sarcoma working group (TARPSWG)

多灶性和转移性腹膜后肉瘤的管理:大西洋两岸腹膜后肉瘤工作组(TARPSWG)更新的共识方法

2026-01-040
PRE
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma

病例报告:肿瘤浸润淋巴细胞疗法在一名患有转移性黑色素瘤和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者中的持久应答

2025-11-170
OAAI
Defining the tumor-infiltrating lymphocyte antigenic landscape in head and neck cancer
2025-11-010
PRE
Collagenolytic Enterococcus faecalis induces DDR1 signaling, proliferation and altered immune infiltrate in colorectal peritoneal metastases

胶原酶肠球菌 *Enterococcus faecalis* 诱导结直肠癌腹膜转移中的DDR1信号通路、增殖和免疫浸润改变

2025-11-011
OA
Radiologic and Pathologic Response Evaluation After Neoadjuvant Chemotherapy for Primary Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Collaboration

原发性腹膜后肉瘤新辅助化疗后的放射学和病理学反应评估:一项大西洋-澳大拉西亚腹膜后肉瘤工作组(TARPSWG)合作研究

2025-05-150
PRE
Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes

超过1300例不同组织学亚型的肉瘤的基因组、转录组及免疫基因组景观

2025-05-060
OA
Oncolytic Viral Therapy in Osteosarcoma
2024-07-161
OAAI
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

新抗原特异性CD4肿瘤浸润淋巴细胞是转移性黑色素瘤患者过继细胞治疗产品中确定的有效效应物

2023-10-0610
OAAI
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
2022-10-1015
OA